Role of GABA in anxiety and depression

被引:377
作者
Kalueff, Allan V.
Nutt, David J. [1 ]
机构
[1] Univ Bristol, Sch Med Sci, Psychopharmacol Unit, Bristol BS8 1TD, Avon, England
[2] NIMH, Clin Sci Lab, Bethesda, MD 20892 USA
关键词
GABA; anxiety; depression; benzodiazepine receptors; common pathogenesis;
D O I
10.1002/da.20262
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
This review assesses the parallel data on the role of gamma-aminobutyric acid (GABA) in depression and anxiety. We review historical and new data from both animal and human experimentation which have helped define the key role for this transmitter in both these mental pathologies. By exploring the overlap in these conditions in terms of GABAergic neurochemistry, neurogenetics, brain circuitry, and pharmacology, we develop a theory that the two conditions are intrinsically interrelated. The role of GABAergic agents in demonstrating this interrelationship and in pointing the way to future research is discussed.
引用
收藏
页码:495 / 517
页数:23
相关论文
共 348 条
  • [1] ALEY KO, 1989, N-S ARCH PHARMACOL, V339, P306
  • [2] Altshuler L L, 1999, Bipolar Disord, V1, P61, DOI 10.1034/j.1399-5618.1999.10113.x
  • [3] AMANO K, 1978, APPL NEUROPHYSIOL, V41, P66
  • [4] The role of corticotropin-releasing factor in depression and anxiety disorders
    Arborelius, L
    Owens, MJ
    Plotsky, PM
    Nemeroff, CB
    [J]. JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) : 1 - 12
  • [5] Anhedonia and chronic mild stress model in depression
    Argyropoulos, SV
    Nutt, DJ
    [J]. PSYCHOPHARMACOLOGY, 1997, 134 (04) : 333 - 336
  • [6] The psychobiology of anxiolytic drugs - Part 2: pharmacological treatments of anxiety
    Argyropoulos, SV
    Sandford, JJ
    Nutt, DJ
    [J]. PHARMACOLOGY & THERAPEUTICS, 2000, 88 (03) : 213 - 227
  • [7] The use of benzodiazepines in anxiety and other disorders
    Argyropoulos, SV
    Nutt, DJ
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1999, 9 : 407 - 412
  • [8] Anxioselective Compounds Acting at the GABAA Receptor Benzodiazepine Binding Site
    Atack, John R.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (04) : 213 - 232
  • [9] Anxiogenic properties of an inverse agonist selective for α3 subunit-containing GABAA receptors
    Atack, JR
    Hutson, PH
    Collinson, N
    Marshall, G
    Bentley, G
    Moyes, C
    Cook, SM
    Collins, I
    Wafford, K
    McKernan, RM
    Dawson, GR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (03) : 357 - 366
  • [10] ATACK JR, 2005, EXPERT OPIN INV DRUG, V14, P599